Sage Therapeutics currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Cytokinetics announced that it has begun enrolling ...

EPD is set to generate additional fee-based earnings with major capital projects either currently in service or under construction.

Strength in the Server & Storage System segment is likely to have aided SMCI's top and bottom-line growth in the second ...

Tesla makes a magnificent return to join Meta and Google. But the best mutual funds can't get enough of Axon and 5 others.

European shares were edging lower on Friday as investors waited for monthly U.S. labor market data. The continent's flagship ...